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Evaluating the Use of Engineered Nervous Tissue Constructs in the Repair of
Peripheral Nerve Lesions and Amputations
Abstract
Severe trauma to the limbs can often result in the lesioning, or even amputation, of the underlying
peripheral nerves. In these cases, endogenous neural repair mechanisms are compromised and a path to
the end target may be lost, resulting in the need for surgical intervention. Current repair strategies are
incapable of maintaining this regenerative pathway, or providing a bridge to a surrogate end target, often
resulting in incomplete repair.
This thesis describes the development and evaluation of a novel method of addressing peripheral nerve
lesions and amputations that utilizes living tissue-engineered neural grafts. These grafts are created by
the controlled mechanical separation of axons spanning integrated neuron populations in vitro, resulting
in axon tracts spanning several centimeters in length. Techniques were developed to encapsulate and
transplant these tracts, with the goal of providing structural and nutrient support, while minimizing
macrophage infiltration. The efficacy of these constructs in the treatment of lesions and amputations was
then assessed using a rat sciatic nerve transection model.
In the first study, the ability of neural constructs to (a) encourage host regeneration from the proximal
stump, while also (b) attenuating distal pathway degeneration, was evaluated. At the 4-week time point,
the axonal constructs were observed to promote more robust host axonal and tissue regeneration across
the graft when compared to unstretched grafts. A measurement of nerve conduction velocities also
revealed a statistically significant improvement in the stretch-grown group, correlating with the observed
increased fiber regeneration. At the distal pathway, neural constructs were observed to prevent the
atrophy of the support cells, and maintain the alignment of the Schwann cell columns for up to 4 months.
These results suggest that the use of neural grafts may expand the time window within which successful
nerve regeneration can occur.
The axon grafts were then shown to support and maintain regenerating host axon fibers for up to 4 weeks
in the absence of a distal end target. Finally, axon grafts pre-attached to an implantable electrode
substrate were shown to encourage host ingrowth to the vicinity of the substrate, showing promise for the
development of a chronic brain-machine interface.
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ABSTRACT
EVALUATING THE USE OF ENGINEERED NERVOUS TISSUE CONSTRUCTS
IN THE REPAIR OF PERIPHERAL NERVE LESIONS AND AMPUTATIONS
Niranjan Kameswaran
Douglas H Smith, MD

Severe trauma to the limbs can often result in the lesioning, or even
amputation, of the underlying peripheral nerves. In these cases, endogenous
neural repair mechanisms are compromised and a path to the end target may be
lost, resulting in the need for surgical intervention. Current repair strategies are
incapable of maintaining this regenerative pathway, or providing a bridge to a
surrogate end target, often resulting in incomplete repair.
This thesis describes the development and evaluation of a novel method
of addressing peripheral nerve lesions and amputations that utilizes living tissueengineered neural grafts. These grafts are created by the controlled mechanical
separation of axons spanning integrated neuron populations in vitro, resulting in
axon tracts spanning several centimeters in length. Techniques were developed
to encapsulate and transplant these tracts, with the goal of providing structural
and nutrient support, while minimizing macrophage infiltration. The efficacy of
these constructs in the treatment of lesions and amputations was then assessed
using a rat sciatic nerve transection model.
v

In the first study, the ability of neural constructs to (a) encourage host
regeneration from the proximal stump, while also (b) attenuating distal pathway
degeneration, was evaluated. At the 4-week time point, the axonal constructs
were observed to promote more robust host axonal and tissue regeneration
across the graft when compared to unstretched grafts. A measurement of nerve
conduction velocities also revealed a statistically significant improvement in the
stretch-grown group, correlating with the observed increased fiber regeneration.
At the distal pathway, neural constructs were observed to prevent the atrophy of
the support cells, and maintain the alignment of the Schwann cell columns for up
to 4 months. These results suggest that the use of neural grafts may expand the
time window within which successful nerve regeneration can occur.
The axon grafts were then shown to support and maintain regenerating
host axon fibers for up to 4 weeks in the absence of a distal end target. Finally,
axon grafts pre-attached to an implantable electrode substrate were shown to
encourage host ingrowth to the vicinity of the substrate, showing promise for the
development of a chronic brain-machine interface.
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Chapter 1

Introduction
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Chapter 1: Introduction

1.1 Clinical Relevance
Peripheral nerve (PN) trauma is a serious condition affecting 2.8% of trauma
patients annually [Chiono V et al, 2009]. This form of injury is primarily caused
by traumatic accidents, tumor resection or iatrogenic effects of surgeries such as
orthopedic procedures [Kretschmer T et al, 2001], and can often lead to lifelong
pain and disability. Etiologies of PN trauma include penetrating injury, crush and
ischemia [Robinson LR, 2004]. Upper limb injuries occur in over 70% of reported
cases, with the ulnar nerve being most frequently damaged.
Table 1.1 – The Sunderland Classification of Nerve Injury
Sunderland Scale
First degree
Second degree
Third degree
Fourth degree
Fifth degree

Description
Neurapraxia – segmental demyelination
Axonotmesis with intact endoneurium
Axonotmesis with damaged endoneurium, intact perineurium
Axonotmesis with damaged perineurium, intact epineurium
Neurotmesis – disruption of entire nerve trunk

Campbell WW, 2008
The Sunderland classification is a widely used scheme for classifying
peripheral nerve injury [Table 1.1] (Sunderland S, 1990). According to this scale,
the mildest form of PN injury is neurapraxia, or segmental demyelination, which
results in an inability of the nerve to conduct action potentials across the affected
region.

The loss of function persists until subsequent remyelination, and is

typically resolved within 12 weeks. Axonotmesis, which is most often associated
2

with crush injuries, refers to the loss of continuity of the axon wherein the
ensheathing structures remain at least partially undamaged.

Repair typically

occurs naturally, and the extent of recovery is thought to be a function of the
location of the injury and the degree of disruption of the surrounding stroma. The
most severe form of PN lesion is neurotmesis. Here, the entire nerve trunk is
severed and the ability of the axons to functionally reconnect with their targets is
severely compromised. This type of injury typically requires surgical intervention,
and even minor functional recovery can take several months using current
treatments [Campbell WW, 2008].
The most debilitating form of PN damage occurs as a result of limb
amputation.

Without presentation of a distal target, the proximal neurites

frequently undergo extensive collateral branching, resulting in either inaccurate
innervation of surrounding tissue or the formation of painful neuromas. Although
the nerve remains electrophysiologically functional, there currently exists no
chronic means of recording its activity.

1.2 Hypotheses and Goals
By exploiting a newly discovered method of creating axonal tracts in vitro
using mechanical tension, we have been able to create transplantable nerve
constructs that can be used to repair damaged axonal tracts and nerves. In the
following studies, the applicability of these nerve grafts in the repair of PNS
3

lesions and amputations is assessed. The study design was motivated by the
following hypotheses: (1) neural constructs can provide regenerative support for
the proximal stump while attenuating degeneration of the distal pathway, and (2)
living axonal constructs can provide support for the extension and maintenance
of regenerating neurites in the absence of a distal target.
In chapter 2, a synopsis of the stretch-growth mechanism and its
adaptability for various therapeutic applications is provided. Chapter 3 describes
the development of techniques to encapsulate and transplant nervous tissue
constructs into a rat sciatic nerve lesion. Chapter 4 illustrates the beneficial
effects of using these constructs for (a) repairing a short nerve lesion, and (b)
maintaining the support architecture at the distal stump, potentially increasing the
window for successful target reinnervation.

Finally, chapter 5 describes how

these axonal constructs can be used to (a) extend and maintain regenerating
proximal axons in the absence of a distal target, and (b) encourage host axonal
growth towards an electrode substrate, which may ultimately enable bi-directional
communication with the peripheral nervous system. A synthesis of these findings
is provided in chapter 6, as well as future work for this field of study.

4

Chapter 2

Overview of Stretch‐induced Axonal
Growth
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Chapter 2: Overview of Stretch-induced Axonal Growth

The study of axon growth has traditionally comprised two distinct areas –
growth cone extension and guidance during embryogenesis, and nerve
regeneration following traumatic injury. In both these cases, the axon has a free
end that advances towards its final target using chemotaxic and/or haptotaxic
cues. However, we now know that there is a third form of axon growth that
occurs after synaptic integration with the target, and is triggered by the
application of mechanical tension.

This form of growth, which we dub “stretch-

growth”, is a newly discovered phenomenon that challenges long-held notions on
axonal transport and protein assembly, and could potentially transform our
understanding of post-embryonic nerve development.

Traditional concepts on axon growth
Growth

cone

motility

and

axonal

pathfinding

during

embryonic

development has been extensively studied over the years [Dickson, 2002; Yu
and Bargmann, 2001; Tessier-Lavigne and Goodman, 1996].

During this

process, pioneer axons forge the initial path to the target, following which all
other axons advance. The pioneer axons are influenced by the push-pull effect
6

of attractive and repulsive chemotaxic cues in the surrounding milieu, as well as
the internal mechanical forces generated at the tip of the growth cone. Trailing
axons, on the other hand, are believed to respond to a combination of these
chemotaxic cues and contact-influenced guidance. Protein assembly has been
shown to occur within the growing tip.

Developing axons grow at a rate of

approximately 1mm/day, and this phase of neurogenesis is typically complete
within 8 weeks in humans.
The other form of axon growth that has been extensively researched is
post-trauma regeneration.

Here, the proximal segment of a transected axon

attempts to rejoin its target by a process remarkably similar to that seen during
development. After injury, the neuron shifts from a transmitting mode to a growth
mode resulting in a growth cone lamelipodial formation at the tip (Dahlin, 2006).
This growth cone is guided across the lesion primarily via chemoattractive and
chemorepulsive cues until it reaches the distal support cells, after which the
guidance is primarily contact-mediated (Mueller, 1999; Goodman, 1996). The
response to injury can begin within hours of the insult and may persist for as long
as 12 months [Campbell WW, 2008].
While both of these forms of axonal outgrowth are essential for the
formation and maintenance of the nervous system, neither can account for the
rapid growth of already-integrated axonal tracts in the fetus and thereafter. Since
the axons no longer having growing tips, the rapid expansion must occur by a

7

completely different mechanism, a process of stretch-growth that we are only
now beginning to understand.

Stretch-growth – a newly discovered form of axonal growth
The use of mechanical tension to extend the tip of an axon was first
demonstrated in 1984, where a movable substrate was used to tow chick
sensory ganglion growth cones [Bray, 1984]. This work has expanded upon
since, to induce transient lengthening of the growth cones of single axons in vitro
[Dennerll et al., 1989; Zheng et al., 1991; Heidemann et al., 1995; Chada et al.,
1997]. The interpretation of these findings was that tension generated at the
growth cone (by internal cytoplasmic components) is a key factor for the growth
of axons. However, the idea that external mechanical forces may play a role in
the growth of synaptically-integrated axon tracts was suggested as far back as
1935 by RG Harrison and 1941 by Paul Weiss, who referred to it as “passive
stretching” and “towing” respectively. They noted that at the peak growth of the
human fetus, motor axons in the lower limb grow at rates approaching
1.2mm/day, which is well within the known rates of axonal transport. However,
evidence of far more rapid axonal growth can be seen elsewhere in nature. Axon
tracts in the giraffe neck have a peak growth rate of 2cm/day [Bannister et al,
1996; Dagg and Foster, 1982]. Axon tracts in the blue whale spine are estimated
to grow at even more astonishing rates, potentially exceeding 3cm/day [Smith
DH, 2009]. These observations challenge fundamental notions of neural protein
8

synthesis and transport. The rate of axonal growth has traditionally been thought
to be limited by slow transport – indeed, neurofilament proteins have been shown
to be shipped down the axon at the rate of a few millimeters per day [Brown,
2003; Nixon, 1998a,b; Roy et al, 2000], which is well below the rates described
here. Even at fast transport rates of 300mm/day, it would take over three months
for neurofilament proteins to be carried the 30m distance from the cell body down
the length of a blue whale axon [Smith DH, 2009]. A possible explanation for this
discrepancy could be local synthesis of protein within the axon itself [Alvarez J et
al 2000; Brittis PA et al, 2002], which would preclude the need for such longdistance transport.

Experimental verification of stretch-growth using rat primary cortical neurons
The development of techniques to create transplantable stretch-grown
axon tracts evolved from in vitro experiments examining traumatic axonal injury
[Wolf et al, 2001] using rat primary cortical neurons.

In these experiments,

tension was transiently applied to axons spanning two neural populations
spanning a short gap with the goal of producing a deleterious effect. However, it
was noticed that the axons demonstrated a resilience to stretch at less rapid
strain rates. Expanding upon these findings, an in vitro stretch-growth model
was developed wherein axons spanning two populations of either cortical or Ntera 2 cell line neurons were allowed to integrate over several days and then
were slowly separated using a micro-stepper motor (Figure 2.1).
9

In initial

studies, the populations were separated at the rate of 3.5µm every 5 minutes,
resulting in 1cm axon tracts after 10 days of stretch-growth (Figure 2.2, left). The
axons were also seen to coalesce into highly organized fascicles (Figure 2.2,
right), potentially replicating the mechanism of organized axonal tract formation
during development [Smith et al, 2001].

Figure 2.1: Axon stretch‐growth device. Integrated axon tracts in the
stretching frame are mechanically separated in a controlled manner by the
computer‐controlled micro‐stepper motor system.

10

Figure 2.2: Left – The stretch growth of cortical axon tracts as seen at 2,
4 and 7 days. Adjacent fibers gradually coalesce into aligned axon
bundles. Right – Confocal image of cortical axon bundles after 7 days of
stretch-growth.
Smith DH et al, 2001
2.1.4 Extreme stretch-growth of rat dorsal root ganglion axons
With a view towards development of a transplantable axonal construct for
eventual clinical usage, dorsal root ganglia (DRG) neurons were selected as our
primary cell source. Adult human DRG neurons can be harvested from patients
undergoing elective ganglionectomies, making them a viable autologous cell
source. Human and animal DRG neurons are also known to be robust in culture,
and can survive for extended periods of time while maintaining normal
electrophysiological function [Pfister et al, 2006a,b].
Subsequent experiments revealed strain rate and acclimation to be the
main determining factors for successful stretch-growth. Starting at the low rate of
1mm/day, the strain rate could be gradually increased, provided the axons were
given a sufficient “rest period” in order to acclimate (Figure 2.3a). By employing
11

this strategy, growth rates of up to 1cm/day were reached within a few days of
commencing stretch-growth [Pfister et al 2004]. In addition, integrated axonal
tracts of up to 10cm length could be created in less than 2 weeks (5cm length
shown in Figure 2.3b).

Figure 2.3: Left – Graphical representation of acceptable stretch-growth
parameters for DRG neurons. Right – DRG axon tracts in culture spanning
5cm.
Despite these high-growth rates, the stretch-grown axons were seen to
possess a normal morphology. However, the average diameter of these axons
was measured to be 30% greater than non-stretched DRG axons, possibly in
order to sustain increased stability and transport.

Transmission electron

microscopy revealed a normal complement of microtubules and neurofilaments
per cross-section area. In addition, the axons were shown to be able to conduct
12

normal action potentials, although they did appear to possess an increased
density of sodium and potassium channels [Pfister et al, 2006a,b].

Using stretch-grown axon tracts to repair the nervous system
In addition to providing insight into the mechanisms of axon growth during
development, stretch-grown axonal constructs may be exploited for nerve repair.
Living nerve tracts can be rapidly created to any desired length in vitro and
transplanted to bridge even extensive central and peripheral nervous system
lesions. In the case of spinal cord repair, transplanted axonal tracts were used to
bridge a 1cm defect spanning three vertebrae in the rat. The constructs were
seen to survive and remain structurally intact one month post-transplantation

Figure 2.4: Survival of transplanted stretch-grown axons in
the spinal cord at 1 month. The transplanted cells (indicated
by the arrows) were found sandwiched between layers of
collagen in the SCI cavity.
Iwata A et al, 2006
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(Figure 2.4) [Iwata A et al, 2006]. Evidence of host axon penetration into the
graft area, as well as graft neurite outgrowth into the host tissue, was also
observed.

It is still unclear whether the constructs form functional synaptic

connections with the host – however, these results demonstrate the feasibility of
this approach and merit further investigation.

Figure 2.5: Left – Transplanted stretch-grown axonal construct used in
the repair of a PNS lesion. The constructs were seen to survive over
several weeks in vivo, and robust intermingling of host (red) and graft
(yellow) axons could be clearly seen. Right – A transverse section of
the graft revealing axons (green) encircled by myelin sheaths (red).

Axonal constructs have also been used to bridge 1cm lesions in the rat
sciatic nerve (Figure 2.5). The graft tissue was seen to survive for at least 4
months without immunosuppression.

Robust intermingling of host and graft

axons was seen in the repaired lesion area as well as in the proximal and distal
nerve segments, indicating graft neurite outgrowth into the host. Analysis of
14

cross-sections of these nerve segments revealed robust regeneration and
myelination of the axons.

Stretch-grown axons from Human dorsal root ganglia
Ultimately in order to be clinically viable, axonal constructs will need to be
generated from autologous tissue.

As previously mentioned, human DRG

neurons can be isolated from patients undergoing elective ganglionectomy
procedures, and can be successfully maintained in vitro. We have been able to
obtain ganglia from live human patients, as well as from organ donors, and have
maintained the tissue in culture for at least 3 months, replicating the findings of
other studies. We have also been able to create stretch-grown axonal constructs
from these human DRGs, thus demonstrating the feasibility of this approach
[Huang J et al, 2008].

15

Figure 2.6: Fluorescence micrographs of adult human DRG neurons
and axons. The human DRG neurons were labeled using (A) CGRP or
neurofilament proteins; (B) RMO-254; (C) SMI-31; and (D)
neurofilament-200. Bottom – Aligned fascicles seen upon stretchgrowth of human DRG axons.
Huang J et al, 2008
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Chapter 3

Development of Nervous Tissue
Encapsulation Techniques
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Chapter

3:

Development

of

Nervous

Tissue

Encapsulation Techniques

With the goal of creating transplantable axonal tracts that may be used to
bridge CNS and PNS lesions, we have developed techniques to encapsulate and
remove the constructs from the in vitro environment without disrupting their
structural integrity and alignment.

The two major components required for

transplantation are an embedding hydrogel and an encapsulating nerve guidance
channel. The primary criteria behind hydrogel selection were structural support
offered, ability to incorporate nutrient supply and permissiveness to neurite
outgrowth.

While our initial design solely consisted of a simple collagen

hydrogel, it has since evolved to include a variety of materials, each serving a
unique and critical purpose.

Initial design – collagen hydrogel

The first material employed for construct encapsulation and
removal was a simple collagen hydrogel (3.67mg/mL) in Dulbecco’s modified
Eagle’s medium supplemented with nerve growth factor (2.5S, 10ng/mL). The
collagen matrix was gently applied over the construct axons and allowed to
polymerize in the incubator at 37°C. Upon gelation (typically 10-15 minutes) the
cell cultures lift off the underlying Aclar membranes and become completely
18

immersed in the collagen. The embedded axons are then rolled along the axis of
the tracts, and the entire hydrogel-tissue combination is deposited into a nerve
guidance channel cut open lengthwise [Iwata et al, 2006].
This approach has several disadvantages. While the 80% collagen
does provide a permissive environment for neurite growth and is seeded with
growth factors, the structural support offered for the axons is minimal. Removal
from the culture environment using this technique can be precarious – axon
tracts are regularly damaged and discarded during the removal process, and
there is no certain way of determining if they are intact even upon successful
transference into the tube. With the goal of overcoming these limitations, and
facilitating easier removal from the culture environment, a variety of additional
hydrogel components were systematically evaluated.

Incorporation of agarose hydrogel

Agarose is a naturally occurring polysaccharide that has been extensively
studied in PNS repair. It can be easily formulated to a wide range of stiffnesses,
each of which has different effects on neurite outgrowth. Neither central nor
peripheral neurons have any known receptors that interact with agarose side
chains.
Our first goal was to evaluate the range of gel stiffnesses that could be
applicable to the construct encapsulation and transfer procedure. It has been
shown by other groups [Balgude AP et al, 2000] that DRG neurite outgrowth is
19

inversely proportional to the stiffness of the gel used, with minimal outgrowth at
formulations exceeding 2% (wt/vol). Our initial design assessment, therefore,
was limited to agarose formulations of 0.5-2.0% (wt/vol).

3.1 Materials and Methods:

Agarose is water-soluble at temperatures exceeding 65°C and typically
gels at a temperature range of 17-35°C. It is clear and stable once gelled, and
does not re-liquefy until heated above 65°C again. The agarose gels used in this
experiment were created in the range of 0.5% to 2.0% (0.25% increments, wt/vol)
by heating and stirring agarose powder (Ultrapure; Invitrogen, Carlsbad, CA) in
pH 7.4 1x Dulbecco’s phosphate buffered saline (PBS; Gibco, Grand Island, NY).
Dorsal root ganglion neurons were isolated from embryonic day 15 fetuses
from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA) rats. The
DRG explants were suspended at 5x106 cells/mL in Neurobasal® medium
supplemented with 2% B-27, 0.4 mM L-glutamine, 1% penicillin/streptomycin, 2
mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10 ng/mL 2.5S nerve growth
factor (NGF) and 1% fetal bovine serum (FBS) (HyClone, Logan, UT), and a
mitotic inhibitor formulation of 10 mM 5-fluoro-2’-deoxyuridine (FdU) (SigmaAldrich), and 10 mM uridine (Sigma-Aldrich) to encourage non-neuronal cell
elimination.

20

3.2 Results

Evaluation of agarose as an encapsulating medium
The isolated DRG explants were initially plated at the interface of two
overlapping membranes of Aclar pre-coated with rat-tail collagen (3.67mg/mL) in
order to approximate initial stretch-growth conditions.

After allowing the

populations to integrate over 5 days, liquefied agarose formulations at 37°C were
added directly over the cultures and allowed to gel by cooling them to 4°C for 2
minutes, followed by placing them for 10 minutes in the incubator at 37°C. Using
a cell scraper, the agarose was then gently separated from the underlying Aclar
layers.

At all formulations exceeding 1.5%, the cells remained preferentially

adhered to the underlying collagen substrate and did not separate from the Aclar.
Below 1%, however, the agarose was structurally fragile and transference into
the tube repeatedly resulted in fragmentation of the gel and disconnection of the
integrated axonal connections.

Those instances of successful transfer also

necessitated the length-wise opening of the tubes for insertion and its
subsequent re-suturing. For these reasons the strategy of adding agarose to
already integrated tracts was abandoned, and its use as an underlying substrate
was evaluated.

21

Evaluation of agarose as a base substrate
In the next design iteration, agarose was used as the base substrate on
which the cells were directly plated. Following from our previous findings, the
formulations were now limited to 1.0-1.5%. Liquefied agarose was added to the
bottom Aclar substrate in the elongator chamber, and allowed to gel by cooling it
to 4°C for 2 minutes followed by 10 minutes in the incubator at 37°C. The towing
membrane was then placed over the agarose a thin layer of collagen
(3.67mg/mL) was then coated over the interface and allowed to polymerize in the
incubator overnight. Isolated DRG explants were then added at the interface and

Figure 3.1: Stretch-growth of axons spanning two DRG explants plated
on a 1.25% agarose hydrogel base layer. Scale bar = 1mm
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allowed to adhere and integrate over 5 days. In all 3 formulations (1%, 1.25%
and 1.5% wt/vol) axons were seen to span the two populations (Figure 3.1). In
order to assess ease of removal from the culture environment, matched
concentrations of agarose were added to the neural populations and the towing
membranes were gently separated using a cell scraper. The neurons were found
to remain encapsulated within the hydrogel, and axon tracts could be easily cut
out using a scalpel blade and directly inserted into the tube through the open
ends.

Adaptation of design to incorporate polyimide electrode array

Figure 3.2: Axons spanning the interface of a polyimide electrode array and
the 1,25% wt/vol agarose hydrogel base layer.
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A polyimide electrode array was then incorporated into the design, in
order to develop the optimal parameters for neural-interface encapsulation. After
formation of an initial agarose base layer and placement of the towing
membrane, a thin (1.5mm x 5mm) strip of polyimide was positioned length-wise
over the agarose at the hydrogel-towing membrane interface. A thin layer of
collagen (3.67mg/mL) was added at the towing membrane-polyimide junction,
and more agarose was added to the other end of the polyimide strip to anchor it
in place. As before, isolated DRG neurons were then plated at the interface, and
allowed to integrate over 5 days (Figure 3.2).
During encapsulation and removal from the elongation device, it was
found that the 1% agarose was unable to sufficiently secure the polyimide in
place, resulting in frequent defragmentation of the encapsulated construct during
removal and insertion into the tube. On the other hand, the 1.25% and 1.5%
agarose formulations did not suffer from this structural disintegration. As a result
of these findings, and with the goal of minimizing the agarose stiffness, a final
agarose concentration of 1.25% wt/vol was selected.

In vivo evaluation of encapsulation design
In order to assess the feasibility of this design in vivo, static neural
constructs were generated, encapsulated in 1.25% agarose, inserted into a 1cm
NeuragenTM tube and sutured to the proximal and distal stumps of a transected
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sciatic nerve. The constructs were harvested at 2 weeks and examined for signs
of nerve regeneration, vascularization and/or host immune response. The
agarose was still predominantly intact at this time. Axon infiltration into the tube
was observed, as were signs of vascular ingrowth (Figure 3.3).

In addition

however, ED-1 staining revealed substantial macrophage infiltration into the tube

Figure 3.3: Confocal reconstructions of the regenerating sciatic nerve (GFP+)
within the transplanted construct. (A-B) Axon tracts running longitudinally
along the nerve. (C-D) Revascularization was observed along the outer nerve
perimeter. Scale bars = 50µm
25

(Figure 3.4), and in the general vicinity of the transplanted neurons.

While

macrophages are a necessary element in the degradation of agarose, their
infiltration was perceived to be potentially disadvantageous considering the
presence of the allograft tissue.

Figure 3.4: ED-1 positive cells adjacent to transplanted DRG
neurons, indicating macrophage infiltration. Scale bar = 50µm

Final encapsulation design
With the goal of attenuating macrophage infiltration, salmon fibrin gel
(5mg/ml fibrinogen, 5 NIH units/ml thrombin in Neurobasal) was incorporated into
the final encapsulation design (Figure 3.5). Salmon fibrin has been shown to
degrade more slowly than mammalian fibrin, and is resistive to glial and
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macrophagic infiltration [Ju Y et al, 2007; Georges PC et al, 2006]. Fibrin is also
extensively used as a surgical adhesive, thus making it a clinically appropriate
choice of end sealant.

Figure 3.5: Schematic representing final construct encapsulation design.
The stretch-grown axons, pre-attached to a polyimide electrode array, are
encapsulated in 1.25% agarose hydrogel and inserted into a NeuragenTM
nerve guide. After suturing the tube to the proximal stump, the ends are
sealed using fibrin gel.
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3.3 Conclusion
By exploiting the mechanism of axonal growth, we have been able to
engineer living axonal tracts of several centimeter lengths in vitro. We have
demonstrated our ability to utilize these constructs to repair lesions in the central
and peripheral nervous system. By optimizing the encapsulation techniques, we
have been able to create a stable method of removing the axonal tracts from the
culture environment without disrupting their alignment and structural integrity.
This encapsulation design also permits the incorporation of a thin flexible
electrode substrate for the goal of creating a stable neural interface with the
peripheral nervous system.
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Chapter 4

Repair of Lesions in the Peripheral
Nervous System Using Stretch‐Grown
Axonal Constructs
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Chapter 4: Repair of Lesions in the Peripheral Nervous
System Using Stretch-Grown Axonal Constructs

4.1 Overview
The current ‘gold standard’ for repair of PN lesions are autologous nerve
grafts. These grafts, typically of the sural nerve, provide a physical bridge across
the lesion and supply endogenous biological cues to guide regenerating axons
from the proximal nerve stump to the remaining distal nerve segment. However,
this approach is plagued by permanent loss of harvested nerve function and the
potential formation of painful neuromas [Lundborg, 2004; Sinis et al, 2007].
Furthermore, there are obvious limitations in the supply of donor nerves, making
autografts inadequate to repair extensive nerve damage.

Alternative clinical

approaches to bridge PN lesions include synthetic tubes composed of
poly(glycolic acid) (PGA) or collagen; however, these conduits by themselves
have been only used for bridging relatively small peripheral nerve (PN) gaps
(Dellon, 2006; Trumble et al., 2006).

Moreover, no current strategy

simultaneously addresses the steady degeneration of support cells in the nerve
segment distal to the injury site. This degeneration ultimately severely limits
recovery of function due to the eventual loss of cues to guide regenerating axons
beyond the lesion to their final targets. This need is particularly important in
cases of major nerve lesions where lost nerve segments reach greater than
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several centimeters, or complex lesions to multiple nerves where conventional
approaches are overwhelmed or unsuitable.

In these instances, the rate of

regeneration, ranging between 1-4 mm/day, may result in repair taking months or
even greater than one year, depending on the location of the injury, over which
time the distal support cells no longer remain.

In addition, the end targets

themselves will undergo degeneration and atrophy after a period of denervation,
further impeding functional recovery [Lien SC et al, 2008]. Thus, there is clearly a
need to address the issue of distal pathway degeneration in conjunction with
regeneration of the proximal stump in order to enable complete functional
recovery.
More recently, tissue-engineered solutions have been sought to overcome
the limitations associated with autografts and nerve guidance channels. These
approaches include creating combinations of permissive scaffolds (such as
decellularized grafts or hydrogels), extracellular matrix (ECM), trophic factors,
and glial or stem cells (Evans et al., 2002; Frerichs et al., 2002; Lee et al., 2003;
Yu and Bellamkonda, 2003; Fansa and Keilhoff, 2004; Hu et al., 2005; Stang et
al., 2005; Chalfoun et al., 2006; Keilhoff et al., 2006; Nie et al., 2007). The
importance of anisotropy has been well recognized as an important spatial cue to
direct axon growth, and is typically achieved via gradients (e.g., neurotrophic or
ECM), longitudinally-aligned fibers, or tailored porosity (Matsumoto et al., 2000;
Bellamkonda, 2006; Dodla and Bellamkonda, 2006; Bozkurt et al., 2007).
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Typically, the optimization of these tissue-engineered constructs in vitro focuses
on developing permissive environments for axonal growth cone extension.
Unfortunately, these approaches typically ignore the fact that axonal
outgrowth in vivo occurs along Schwann cells and the basal lamina; thus,
strategies that were optimized based on directly promoting axonal outgrowth in
vitro may not translate mechanistically. In addition, all of these approaches are
geared towards promoting regeneration of the proximal stump; none of these
strategies can delay the eventual degeneration of the distal pathway.
We have recently begun investigating axon-mediated axon outgrowth as
an alterative mechanism of regeneration.

By exploiting the newfound

mechanism of “stretch-growth”, whereby large axon tracts can be created by the
controlled and continuous separation of integrated neural populations, we have
created transplantable neural constructs that have been shown to effectively
bridge a 1cm sciatic nerve lesion in the rat 4 months post-transplantation.
However, the advantage of utilizing stretch-grown axonal constructs vis-à-vis a
simple (or “static”) neural culture was unknown. We also observed evidence of
graft axon outgrowth into the host nerve; this suggests the possibility of
maintaining the distal pathway support architecture by providing a temporary
axonal surrogate, a phenomenon often referred to as nerve “babysitting”.
Therefore, the objectives of this study were to (1) determine if stretch-grown
axons provide an advantage over static cultures in promoting of host
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regeneration, and (2) assess whether axons emerging from the graft can
attenuate the degeneration of the distal nerve segment.

4.2 Repair of a 1cm PNS lesion using stretch-grown axons
4.2.1 Relevant Background
During development of the peripheral nervous system, axons known as
“pioneer axons” prescribe the initial path for subsequent axons to follow in a
process known as “selective fasciculation” [Dickson, 2002; Yu and Bargmann,
2001; Tessier-Lavigne and Goodman, 1996]. The pioneer axons are believed to
enable this targeted axonal outgrowth by a combination of neurotrophic support
and contact guidance. This phenomenon has inspired a variety of strategies in
the area of peripheral nerve repair. Several groups are investigating the use of
growth factors and/or Schwann and glial cell combinations to enhance nerve
growth within nerve guidance channels [Evans et al., 2002; Frerichs et al., 2002;
Lee et al., 2003; Yu and Bellamkonda, 2003; Fansa and Keilhoff, 2004; Hu et al.,
2005; Stang et al., 2005; Chalfoun et al., 2006; Keilhoff et al., 2006; Nie et al.,
2007]. Yet others have shown that axons appear to prefer longitudinally-aligned
fibers [Kim et al, 2008; Bellamkonda, 2006] as a regenerative substrate, and
attempts are being made to create trophic factor-eluting versions of these [Cao et
al, 2009].
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Building upon these findings, we hypothesize that the axonal portions of
the tissue-engineered neural constructs contribute more to host PN regeneration
than static cultures, as they may provide both trophic support, as well as a
longitudinally aligned pre-established pathway that spans the entire lesion. In
this study, we investigate the repair of a 1cm sciatic nerve lesion using
transplants of stretch-grown axonal constructs as well as static neural (dorsal
root ganglion) cultures.

4.2.2 Materials and Methods

Overview of Study Design
Building upon our previous findings on host nerve regeneration at 6 weeks
and 4 months [Huang J et al, 2009], the initial study design required harvesting
the nerve at the 2-week and 4-week time points in order to assess the
progression of the nerve through the graft. However, an assessment of host
regeneration at 2 weeks revealed similar results to the 4-week findings. This can
be attributed to the early time point – within days of repair, the proximal nerve
stump will undergo rapid regeneration and abundant collateral sprouting, both of
which will be maintained for several weeks to months. As a result of these
preliminary observations, the 2-week time point was subsequently discontinued.
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At 4-weeks post-transplantation, the nerves were re-exposed for
electrophysiological

evaluation

and

then

immediately

harvested

for

immunohistochemistry. This time-point was selected since the host nerve would
have regenerated through the length of the transplant, allowing us to compare
the extent (number of axons) and quality (nerve conduction velocity and latency)
of the repair.

Dorsal root ganglion neuron isolation
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA)
rats.

The DRG explants were suspended at 5x106 cells/mL in Neurobasal®

medium

supplemented

with

2%

B-27,

0.4

mM

L-glutamine,

1%

penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10
ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS)
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to
encourage non-neuronal cell elimination.
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Static Nervous Tissue Constructs

Figure 4.1: Schematic representation of the bridging of a 1cm sciatic nerve lesion
using static DRG neuron cultures

The explants were plated into a collagen-filled (rat tail type 1, 3.67mg/mL)
agarose (1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA) trough
measuring 2mm x 1cm.

The cell cultures were allowed to form axonal

connections over 12 days in vitro. The neural growth medium described above
was replaced on post-isolation days 1, 3, 5 and 12.
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Stretch-grown Nervous Tissue Constructs

Figure 4.2: Schematic representation of the bridging of a 1cm sciatic nerve lesion
using stretch‐grown axons

The explants were plated into mechanical elongation chambers customfabricated for the stretch-growth procedure. The neurons were plated in two
populations along the interface of a collagen-coated (rat tail type 1, 3.67mg/mL)
37

aclar “towing” membrane and a base layer of agarose (1.25% in 1X PBS;
Ultrapure, Invitrogen, Carlsbad, CA), resulting in a separation of 50-100µm. Over
5 days in vitro, axonal connections were formed between these two populations.
The populations were then gradually separated over the course of 7 days using a
stepper motor system until the axons spanning them reach a length of 1cm.

Neural Construct Encapsulation
On post-isolation day 12, the neural cultures (both static and stretchgrown) were removed from the incubation chambers and embedded in a
collagen-based matrix (3.0 mg/mL) in Dulbecco’s modified Eagle’s medium
supplemented with NGF (2.5S, 10 ng/mL). After gelation at 37°C, embedded
cultures were gently removed and placed within a 1cm absorbable collagen
nerve guidance channel (3mm inner diameter, NeuraGenTM, Integra LifeSciences
Corp, Plainsboro, NJ).

Peripheral Nerve Surgery and Tissue Construct Implantation
Stretch-grown (n=10) as well as static (n=8) constructs were implanted
into GFP+ rats (adult male, 400-450mg, strain TgN(act-EGFP)OsbCZ-004). The
animals were anesthetized with sodium pentobarbital (Nembutal, 50 mg/kg, i.p.)
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prior to surgery. A longitudinal skin incision was made in the hind leg from the
sciatic notch proximally to the region of the popliteal fossa distally. The gluteal
muscle was freed up to expose the sciatic nerve and its posterior tibial branch. A
1cm segment of sciatic nerve was transected immediately proximal to the
trifurcation. The proximal and distal stumps were carefully inserted into the ends
of the NeuraGenTM tube with an overlap of 1mm, and the epineurium was
secured to the tube using 8-0 absorbable sutures. The ends of the tube were
sealed with salmon fibrin (5mg/ml fibrinogen, 5 NIH units/ml thrombin) to provide
additional stability, and to attenuate macrophage infiltration into the tube. Finally,
the muscle and skin layers were sutured over the graft with absorbable chromic
gut 4-0 sutures.

Nerve Electrophysiology
The sciatic nerve was re-exposed and 4 weeks (n=6) using the
aforementioned procedure. The animal was placed on a heating pad to maintain
body temperature at 37°C. A stimulating electrode was placed 2mm proximal to
the transection site, and the recording cuff was placed 2mm distal to the graft.
All recordings were obtained at a sampling frequency of 4000 samples/s for 20s
(MP-150; Biopac Systems Inc, Goleta, CA). Stimulation was provided using a
50µA, 100µs, constant current pulse train (SIU-91A; Cygnus Technology,
Delaware Water Gap, PA); the current pulse train was controlled by a gating
command from the recording unit in order to accurately calculate the conduction
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velocity. The procedure was repeated on the contralateral side for each animal,
and the ratio of conduction velocity of the operated side to the non-operated
nerve was determined. All related data analyses were performed using standard
software (Acknowledge 3.9.1; Biopac Systems Inc, Goleta, CA).

Nerve Harvest and Histological Analyses

Figure 4.3: The grafted neural construct (indicated by the
arrow) being harvested at the 4-week time point. The
collagen tube can be seen to be securely fastened to the
proximal (left) and the distal (right) nerve segments. Note
the negligible fibrotic response around the tube.
Immediately following electrophysiological evaluation, the constructs were
harvested by transecting the nerve 2mm proximal and 2mm distal to the graft
(Figure 4.3), and were placed in 4% paraformaldehyde.
euthanized by an overdose of sodium pentobarbital.
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The animals were

Following overnight fixation in paraformaldehyde, the excised tissue was
removed and immersed in 30% sucrose solution.

The tissue was then

cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) myelin basic protein (MBP;
SMI-94R, 1:500, Covance Research Products, Princeton, NJ), (iii) S-100 (1:500;
Dako, Carpinteria, CA), or (iv) calcitonin gene-related peptide (CGRP; C8198,
1:1000 Sigma-Aldrich). The appropriate secondary fluorophore-conjugated
antibodies (TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West
Grove, PA) were used. The sections were examined under an epifluorescent
microscope (Eclipse E600; Nikon, Melville, NY) and the images were digitally
captured (Spot RT Color; Diagnostic Instruments, Sterling Heights, MI).
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4.2.3 Results

Stretch-grown and static neural construct survival

Figure 4.4: Static cultures of dorsal root ganglion neurons were
clearly identified in the tube. Clusters of cell bodies and their
associated axonal connections (indicated by the arrows) were
recognized using NF-200 staining (red), and could be distinctly
identified against the host tissue (GFP, green). Note that no colocalization could be seen in their vicinity, indicating the lack of
host and graft axon intermingling in the area.

Stretch-grown constructs were harvested at the 4-week (n=6) and 8-week
(n=2) time points. All static constructs (n=6) were harvested 4-weeks posttransplantation.

At both time-points the transplanted area could be clearly

identified as the collagen tube was still un-resorbed and maintained its structural
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integrity. Within the tubes the transplanted ganglia and their axonal connections
were identified using the neuronal/neuritic cytoskeletal protein NF-200; these
areas did not co-localize with green fluorescent protein, indicating non-native
tissue (Figure 4.4).

Examination of the grafts also revealed robust

vascularization along their entire lengths, which is a necessary requirement for
the survival and maintenance of host and graft tissue. Also, as observed in our
previous studies, there was no overt sign of immunologic response as denoted
by infiltrating macrophages and neutrophils despite the lack of immune
suppressant usage.

Host regeneration across stretch-grown constructs
Host nerve fibers were seen to extend across the length of the 1cm lesion
in the stretch-grown as well as the static neural transplants (Figure 4.5).
However, far most extensive host infiltration (neural and vascular) could be seen
in the stretch-grown group, whereas the static group had preferential neurite
growth along the walls of tube.

The host fibers were identified as those

expressing NF-200 co-localized with GFP (Figure 4.6 A-C). Remnants of the
agarose were still present at 4 weeks; the axons were seen to grow between the
agarose and the walls of the collagen tube in both cases, presumably due to the
relative impermeability of the still-disintegrating agarose fragments.

After 8

weeks in vivo, however, the nerve and accompanying vasculature was
distributed through the width of the tube and the agarose could not be detected.
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Figure 4.5: Comparison of host nerve regeneration
through stretch‐grown axon group (left) and static culture
group (right). In the static group, host tissue appeared to
preferentially regenerate along the walls of the collagen
tube, whereas tissue distribution was more uniform in the
stretch‐grown axon group.
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At 4 weeks, all constructs were also seen to contain GFP+/S-100+
Schwann cell bodies in the vicinity of the host axon fibers (Figure 4.6D). These
same cell bodies did not positively express myelin basic protein (SMI-94),
suggesting that they had not yet converted into a myelinating phenotype.
As previously mentioned, the constructs were also evaluated at 2 weeks
(n=2 per group). However, as no measurable differences were observed when
compared with the 4-week time point, evaluation at 2 weeks was discontinued.

Figure 4.6: (A-C) Host regeneration within the construct. NF-200 staining
(red) was expressed by both host and graft axons. Areas of co-localization
(white arrow) indicate host axon fibers. (D) Schwann cells expressing S-100
(green) surrounding host axons (red) Scale bar = 100µm.
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Electrophysiological assessment

Comparison of Normalized Conduction
Velocities at 4 weeks
Percentage of contralateral side

4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Stretch‐grown axons

Static Cultures

Figure 4.7: Comparison of conduction velocities (CV) of the stretch-grown
and static culture groups expressed as a percentage of the contralateral (CV).
The difference was found to be significant (p<0.05).
Evaluation of the electrophysiology of the repaired nerves at 4 weeks
revealed clear differences between the stretch-grown and static groups. The
ratio of the conduction velocities of the treatment and contralateral control sides
were calculated, and nerves with stretch-grown axons demonstrated a
statistically significant improvement over static cultures.

This correlates with

observed differences in regenerated axonal fiber density. It should be noted that
the recorded conduction velocities are less than twenty times that of normal
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nerves. This could be attributed in part to the still-incomplete regeneration as well
as the previously noted absence of myelination.

4.3 Attenuation of distal degeneration using a neural construct
4.3.1 Relevant Background
Following the transection of a nerve, distal axons – which have been
physically cut off from their neural cell bodies – undergo a gradual degenerative
process known as Wallerian degeneration. Within a few hours of transection, the
axolemma fuses and seals the end; the axons themselves begin to disintegrate
within a few days.

Myelin and other cellular debris are phagocytosed by

macrophages within 6 weeks. Concurrent with the loss of the axons, Schwann
cells begin to proliferate at the site of the injury and organize themselves into
aligned columns known as bands of Bungner (Figure 4.8). These Schwann cells
upregulate their synthesis of neurotrophic factors including NGF, BDNF and NT-3
[Heumann, 1987; Thoenen et al, 1988; Funakoshi et al, 1993; Fu and Gordon,
1995; Raivich and Makwana, 2007] in order to attract regenerating axons of the
proximal stump into the aligned columns. If regeneration is successful, axonal
sprouts will advance through the bands of Bungner and ultimately innervate their
appropriate distal targets within a few (3-6) months of the injury. If reinnervation
does not occur within this timeframe, however, the recovery is likely to be
incomplete [Fu and Gordon, 1995; Gutmann and Young, 1944]. A progressive
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increase in the collagen content of the endoneurium and perineurium can lead to
an inhospitable environment for regenerating axons [Salonen et al, 1985].
However, the predominant factor contributing to this poor recovery is the gradual
reduction of neurotrophic support and eventual disintegration of the Schwann cell
basal lamina [Sunderland, 1950], which is almost entirely complete within 4-6
months.

Figure 4.8: Example of columnar alignment of Schwann cells (S-100, green)
in the sciatic nerve 2 weeks post-transection. Scale bar = 50µm.
Image courtesy Cullen DK, 2008
A variety of strategies have been investigated with the goal of delaying
this distal atrophy and improving functional outcome. In the case of proximal
nerve injuries or long nerve gaps, clinicians regularly perform distal motor nerve
transfers in order to hasten muscle reinnervation [Mackinnon, Roque and Tung,
2007]; however, this results in impaired function at the donor site. Moreover, in
many situations a suitable motor nerve candidate is simply not available.
48

Sensory nerve innervation of the distal stump has been shown to maintain a
favorable neurotrophic milieu for at least 6 months post-transection [Michalski et
al, 2008; Bain et al, 2001]. Here too, however, the sacrifice of an otherwise
healthy nerve is required for improvement of outcome at the graft site.
Building upon these approaches, and our observation of graft
axons extending into the host nerve stumps [Huang J et al, 2009], we
hypothesize that axonal processes extending from a transplanted neural
construct may maintain the support architecture of the distal segment, potentially
leading to improved functional recovery even after delayed reinnervation. In this
study, we compare the extent of degeneration of the distal stump over 16 weeks
after treatment with a transplanted static neural construct vis-à-vis no repair.

4.3.2 Materials and Methods
Dorsal root ganglion neuron isolation
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA)
rats.

The DRG explants were suspended at 5x106 cells/mL in Neurobasal®

medium

supplemented

with

2%

B-27,

0.4

mM

L-glutamine,

1%

penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10
ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS)
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’49

deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to
encourage non-neuronal cell elimination.
Static Nervous Tissue Constructs
The explants were plated into a collagen-filled (rat tail type 1, 3.67mg/mL)
agarose (1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA) trough
measuring 2mm x 1cm.

The cell cultures were allowed to form axonal

connections over 12 days in vitro. The neural growth medium described above
was replaced on post-isolation days 1, 3, 5 and 12.

Figure 4.9: Schematic representation depicting the use of neural constructs to
innervate and protect the transected distal stump
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Neural Construct Encapsulation
On post-isolation day 12, the neural cultures were removed from the
incubation chambers and embedded in a collagen-based matrix (3.0 mg/mL) in
Dulbecco’s modified Eagle’s medium supplemented with NGF (2.5S, 10 ng/mL).
After gelation at 37°C, embedded cultures were gently removed and placed
within a 1cm absorbable collagen nerve guidance channel (3mm inner diameter,
NeuraGenTM, Integra LifeSciences Corp, Plainsboro, NJ).
Peripheral Nerve Surgery and Tissue Construct Implantation
All procedures were performed using GFP+ rats (adult male, 400-450g,
strain TgN(act-EGFP)OsbCZ-004). The animals were anesthetized with sodium
pentobarbital (Nembutal, 50 mg/kg, i.p.) prior to surgery.

A longitudinal skin

incision was made in the hind leg from the sciatic notch proximally to the region
of the popliteal fossa distally. The gluteal muscle was freed up to expose the
sciatic nerve and its posterior tibial branch, and the nerve was transected 1cm
proximal to the trifurcation. For construct transplantations (n=6), the distal stump
was carefully inserted into one end of the NeuraGenTM tube with an overlap of
1mm, and the epineurium was secured to the tube using 8-0 absorbable sutures.
The ends of the tube were sealed with salmon fibrin (5mg/mL fibrinogen, 5 NIH
units/ml thrombin) to provide additional stability, and to attenuate macrophage
infiltration into the tube. For both neural construct transplantations and controls
(n=6), the proximal stump was capped and the distal stump/tube was covered in
a non-resorbable nylon mesh – these steps were taken in order to prevent
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inadvertent regeneration of the proximal stump into the transection site. Finally,
the muscle and skin layers were closed using absorbable chromic gut 4-0
sutures.

Nerve Harvest at 16 weeks and Histological Analyses
The surgical site was re-exposed at the 16-week time point (with the
exception of one neural construct graft and one control nerve that was left in vivo
for 8 months), and the distal stumps were harvested by transecting the nerve as
far as could be exposed distal to the graft (typically 1cm). The nerves and were
immediately placed in 4% paraformaldehyde and the animals were euthanized by
an overdose of sodium pentobarbital.
Following overnight fixation in paraformaldehyde, the excised tissue was
removed and immersed in 30% sucrose solution.

The tissue was then

cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) S-100 (1:250; Dako,
Carpinteria, CA), or (iii) calcitonin gene-related peptide (CGRP; C8198, 1:1000
Sigma-Aldrich). The appropriate secondary fluorophore-conjugated antibodies
(TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West Grove, PA)
were used. The sections were examined under an epifluorescent microscope
(Eclipse E600; Nikon, Melville, NY) and the images were digitally captured (Spot
RT Color; Diagnostic Instruments, Sterling Heights, MI).
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4.3.3 Results

Distal stump harvest and gross assessment at 16 weeks
Distal stumps from both groups (neural constructs and controls) were
evaluated at the 16-week time point. One non-treated control nerve could not be
harvested, as the distal pathway appeared to have completely disintegrated.
Aberrant regeneration of the proximal stump into the distal pathway was not seen
in any of the animals. The neural constructs could be easily identified by means
of the collagen tubes, which had still not been completely resorbed and
maintained their structural integrity; the nerve stumps remained securely
attached to the tubes. The remaining control nerves could be readily located
beneath the non-resorbable nylon mesh protective sheaths. A pre-histological
comparison of the nerves revealed narrower diameters for the control group in
relation to treated nerves. On average, control nerves were 13.6% smaller in
diameter than the treated group, and 20.8% narrower than uninjured nerves.

Basal lamina alignment and neural construct survival
At the 16-week time point, all distal stumps from both groups contained
intact epineuria and living Schwann cells within them.

Schwann cells were

identified as those expressing S-100 co-localized with GFP.

Within nerves

attached to static neural constructs, the Schwann cells were aligned in columnar
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formations similar to those observed within 2 weeks of nerve transection (Figure
4.10 A-C). In contrast, control nerves did not exhibit this organized Schwann cell
alignment (Figure 4.10 D-F). Despite this disparity, neither dorsal root ganglia
nor host/graft axons could be detected within these columns using NF-200, GAP43 and CGRP staining, suggesting that the neural populations were no longer
present at this time point.

Figure 4.10: The distal nerve stump at the 4-month time point. The treated nerve
(A) was stained for S-100 (red, B) and the super-imposed image (C) revealed
columnar alignment of Schwann cells (yellow) similar to that seen within a few weeks
of transection. On the other hand, control nerves (D), when stained for S-100 (E)
revealed a disorganized arrangement of Schwann cells (yellow, F), as is typically
expected at this time point. Scale bar = 100µm.
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4.4 Discussion
In order for peripheral nerve regeneration to be considered successfully,
axons must grow across the lesion, through the distal pathway and finally
integrate functionally with the appropriate end targets. If this does not occur
promptly, the distal pathway will disintegrate and the regeneration will be
incomplete. In this project, living tissue-engineered neural constructs, created
using a novel stretch-growth paradigm, were used to (1) bridge a 1cm peripheral
nerve lesion, and (2) delay the atrophy of the distal stump support architecture.

Repair of a PNS lesion:
The ability of stretch-grown axons to bridge nerve lesions has already
been shown in previous experiments [Huang et al, 2009; Iwata et al, 2006]. In
this study, the regenerative assistance provided by these stretch-grown
constructs was compared to that provided by non-elongated cultures of dorsal
root ganglion neurons. This was performed in order to confirm that it is indeed
the presence of elongated axon bundles that contribute to enhanced
regeneration, and not the cell bodies. The repaired nerves were evaluated at 4
weeks and 8 weeks. By 4 weeks, the nerves had regenerated in all surviving
animals. At this time-point, the agarose in the tubes was still largely undigested;
indeed the axons appeared to flank the agarose portions and grow along the
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edges of the tubes. The persistence of the agarose at 4 weeks was surprising as
it contradicts previously published reports where agarose was used as a
regenerative substrate [Balgude et al 2001]. A possible explanation is the use of
salmon fibrin as a sealant at the ends of the tube. Salmon fibrin has been shown
to attenuate the infiltration of macrophages, which are known to contribute to the
enzymatic degradation of agarose. In any event, the agarose is not seen at 8
weeks and the tubes solely include host and graft axons as well as
accompanying vasculature.
Despite the uniformly obstructive nature of the agarose at 4 weeks, crosssections of the harvested constructs revealed a greater number of host axons in
stretch-grown constructs than in the non-elongated group. A likely explanation
for this is the preference for regenerating neurites to coalesce around and grow
along longitudinally-aligned fibers within a regenerative matrix [Clements IP et al,
2009; Kim YT et al, 2008]; indeed, these axons appear to be intertwined with
graft fibers.

It is well established that regenerating neurites project an

abundance of collateral branches that are pruned once the distal target is
reached [Witzel et al, 2005; Jenq and Coggeshall, 1985]. The ultimate success
of any graft is highly dependant on the generation of these surplus branches
[Madison et al, 2007], and thus the observed axon density within the stretchgrown constructs is promising.
Clusters of Schwann cells were also identified adjacent to the host axon
fibers. Intriguingly, these cells stained positively for S-100 but not for SMI-94.
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Unlike S-100, SMI-94 is specific to myelin and does not identify non-myelinating
or neoplastic cells (Clark HB et al, 1985) suggesting that these Schwann cells
had not converted to a myelinating phenotype at 4 weeks. However, myelination
of the regenerated axons was observed by the 16 week time point [Huang J et al,
2009], indicating that the phenotypic conversion occurs somewhere within this
time frame. Indeed, regenerated axon myelination has been typically reported at
2 months, and tends to steadily increase from 2-12 months [Mackinnon S et al,
1991].
Electrophysiological evaluation was the clearest indicator of the
differences between the two groups.

The conduction latency across each

transplant in response to a stimulus pulse train was measured from which the
nerve conduction velocities (NCV) were evaluated.

The NCV was then

normalized to contralateral nerve for each animal. This particular metric was
chosen as a consequence of the size disparity between the animals.

A

comparison between the groups revealed a statistically significant improvement
in animals with stretch-grown transplant in relation to the static group.

This

finding can be attributed to the observed difference in the axonal fiber
distributions between the two groups.

It should be noted that the observed

velocities are approximately 20 times less than those of the non-injured nerves.
This can attributed to a number of reasons, principal of which is the absence of
myelination at 4 weeks - saltatory conduction can often occur at up to a hundred
times the speed of a simple action potential. Axon fiber caliber also plays a
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significant role. Regenerating fibers are known to be of a narrower diameter until
they integrate with their end targets, after which they significantly increase in
girth.
The use of living axon grafts may enable the creation of alternative
pathways for communicating motor and sensory signals. Indeed, stretch-grown
axons in vitro have been shown to be electrophysiologically functional including
intra-culture synaptic integration [Pfister BJ et al, 2006]. However, preliminary
work evaluating the presence of synaptophysin, a protein concentrated in presynaptic specializations, did not reveal evidence of host/graft synaptic
integration. Alternative analyses techniques, such as morphological identification
of putative synapses via electron microscopy, may further illuminate this
important consideration.

Attenuation of Distal Degeneration:
The eventual atrophy of the distal stump is a confounding factor when
nerve lesions are either too large or too proximally located. Efforts have been
made to delay this atrophy using sensory nerve innervation; so far, however, no
one method is capable of both promoting regeneration and attenuating distal
degeneration.
In this study, cultures of dorsal root ganglion neurons were encapsulated
and affixed to a transected sciatic nerve distal stump, in order to determine if
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axonal outgrowth and its associated neurotrophic support could maintain neural
support cells over a period of 4 months. The increased degree of atrophy in
control nerves was immediately apparent during nerve harvest – while their
epineuria were still intact, untreated nerves were of considerably narrower caliber
than those attached to the neural constructs.

Control nerves also appeared

structurally less robust, making them difficult to manipulate and harvest.

In

contrast, the treated distal stumps were noticeably more robust.
Histological analysis of the nerves revealed clear differences in the
alignment of survival Schwann cells in both groups. Nerves affixed with neural
constructs contained aligned columns of Schwann cells, similar to the bands of
Bungner observed in the initial weeks following axotomy. In contrast, Schwann
cells in control nerves were distributed in a haphazard manner. The columnar
alignment of Schwann cells is essential for accurate guidance of the regenerating
neurites to their appropriate targets; without this guidance, axons may
occasionally grow along the epineuria directly onto the denervated muscle
surface, resulting in poor reinnervation [Fu and Gordon, 1995]. Absent this path
as well, uncapped axons will innervate surrounding muscle targets, resulting in
the phenomenon of phantom pain.
Despite these observed differences, the neural constructs could not be
detected within the collagen tubes at 4 months, preventing a thorough
assessment of its’ contributions. This was surprising, since neural constructs
used for lesion repair were observed within the transplanted area at the same
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time point.

However, a critical difference between these two results is the

attachment of the proximal stump and subsequent regeneration.

The milieu

surrounding the regenerating nerve is flush with neurotrophic support; however,
on the distal side this support is transient, after which the support structures
undergo aggressive macrophagic degradation [Hoke et al, 2003].

Immune

suppressants, which were not employed in this study, might be a potential means
of prolonging grafted neuron survival.

4.5 SUMMARY OF FINDINGS
Conclusions
From these results, we infer that the stretch-grown axonal constructs
provide a degree of physical and neurotrophic support to the regenerating
proximal stump that is absent when using populations of neural cell bodies alone.
Neural cell bodies do not exist outside of the spinal cord and its immediate
vicinity, suggesting that they may be physiologically irrelevant to outgrowing PNS
neurites. Living axons, on the other hand, have been shown to play a critical role
during embryonic development and in regeneration (such as after crush injury),
and thus may be the essential element of any tissue-engineering approach that
utilizes neural cellular components. At the distal end, infiltrating neurites from the
transplanted neural constructs may provide a measure of trophic support that can
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maintain the existing architecture for several months. While this support appears
to be temporary, it may be sufficient for all but the most extensive of lesions.

Limitations and Future Studies
While the results are suggestive of a beneficial effect from the
transplanted neural constructs at both the proximal and distal ends, a larger
study encompassing more acute and long-term time points is needed to support
these findings. In particular, a more thorough quantification of axon proliferation,
myelination and electrophysiology at various time points must be performed. In
addition, the distal stump maintenance must be evaluated (a) at an earlier time
point in order to assess the effect of the neural constructs, and (b) using immune
suppressants in order to evaluate their ability to promote construct survival over
longer periods.
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Chapter 5

Development of a Neural Interface
Platform with the Peripheral Nervous
System Using Stretch‐Grown Axonal
Constructs
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Chapter 5: Development of a Neural Interface Platform
with the Peripheral Nervous System Using StretchGrown Axonal Constructs

5.1 Overview
Technological advances of the past several decades have now made
interfaces with the nervous system a reality.

The cochlear implant, the first

device to truly interface the nervous system with the external environment, was
developed in the 1960’s. However, the direct neural control of prosthetic limbs is
a far more nascent field. In 1999, a seminal study described the control of a
robotic arm using signals directly derived from the rat motor cortex [Chapin et al,
1999]. Since then, there have been a number of exciting advancements in the
field, in both central- (CNS) and peripheral nervous system (PNS) based
approaches.
The ideal neuroprosthesis should be a functional facsimile of the
amputated limb, i.e. it must facilitate continuous bi-directional communication
between the central nervous system and the external environment. Currently,
the vast majority of efforts in this area focus exclusively on the re-establishment
of motor control, relying on visual feedback to guide the movement of the
prosthesis.

However, in order to achieve truly “normal” interaction with the
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surroundings, tactile feedback is vital.

Additionally, from a clinical and

rehabilitation standpoint, it is important to have an architecture that minimizes
surgical complexity and recovery time, provides a hospitable environment for
nerve survival, and lends itself to rapid learning.
Over the past several decades a variety of architectures that target both
the central and peripheral nervous systems have been developed. CNS-based
approaches attempt to restore motor function by directly deriving commands from
the patient’s motor cortex. Two major strategies have emerged to accomplish
this. The first is a non-invasive technique to obtain movement intent via surface
(scalp) electrodes over the motor cortex [Guger C et al, 1999; Wolpaw JR and
MacFarland DJ, 2004].

Using this approach, which entirely avoids the risks

associated with surgery, patients have demonstrated the ability to perform such
tasks as cursor manipulation and even basic word processing (Figure 5.1, right).
However, the poor information transfer rates associated with this
technique makes its translation to the control of more sophisticated systems
immensely challenging in the near future [Wolpaw JR et al, 2002; Lebedev MA et
al, 2006]. To produce complex signal integration, more invasive methods have
been developed, such as chronically implanted micro- electrodes into the motor
cortex (Figure 5.1, left) or spinal cord to locally record activity from a select
population of neurons [Palmer C, 1978; Maynard EM et al, 1999; Donoghue JP,
2002; Taylor DM et al, 2002; Hochberg LR et al, 2006]. Neuronal population
decoding algorithms are then used to decipher the recorded signals in real-time.
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This approach has yielded considerable success in re-enabling motor control;
indeed, a version of this system is currently the subject of a pilot clinical trial.
Nonetheless, this approach has a number of drawbacks, including substantial
computational complexity, significant clinical risk arising from the chronic
implantation of electrodes in healthy neural tissue, and signal attenuation and/or
remapping due to scar formation. Moreover, findings from functional magnetic
resonance imaging (fMRI) studies indicate that there is extensive and dynamic
overlap of the cortical representations of different limb regions, adding additional

Figure 5.1: Examples of CNS‐based brain‐machine interface systems. Top left –
a penetrative 10x10 cortical electrode array. Bottom left – after removal of the
skull bone, the electrode array is inserted into the motor cortex tissue. Recorded
cortical activity is transmitted to a pedestal connection implanted in the skull
bone, which is then interpreted by an external computer. Right – EEG‐derived
neural interface system using a sensor array mounted on the user’s scalp.
Donoghue JP, 2002; Wolpaw JR et al, 2004
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difficulty to implant positioning and signal decoding [Rao SM et al, 1995].
Additionally, there is still no clear approach to relay sensory signals/feedback.
Alternatively, interface approaches outside the CNS typically take one of
two forms – (1) electrodes that are implanted in or around the damaged
peripheral nerve, or (2) electrodes that are implanted within, or on the surface of,
skeletal muscle [Navarro X et al, 2005]. Nerve electrodes, the form of which can
vary from encircling nerve cuffs [Grill WM and Mortimer JT, 1998] to intra-

Figure 5.2: Top – Non‐penetrative nerve cuff electrode. The
electrode is wrapped around the nerve, and can be tightened to create
a more secure connection.
Bottom – a 10x10 penetrating
intrafascicular electrode array. The array is inserted into the nerve,
and the varying electrode lengths enable recording from fascicles at
varying depths.
Navarro et al, 2005 and Branner et al, 2001
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fascicular penetrating electrode arrays [Warwick K et al, 2003; Branner A et al,
2004] exhibit both enhanced signal selectivity and high signal-to-noise ratio.
However, this approach still has its drawbacks – the materials used are often of
poor biocompatibility, the electrodes themselves can be extremely damaging to
the already traumatized nerves, and there is a reduced likelihood of chronic
interface due to nerve degeneration.
EMG-based myoelectric prosthesis systems have met with remarkable
success in recent years. In particular, the targeted innervation of the brachial
plexus nerves into the pectoral muscles has allowed for the real-time control of
multi-jointed prosthetic limbs [Kuiken TA et al, 2004; Kuiken TA et al, 2007a], as

Figure 5.3: Brain‐machine interface using targeted
innervation of the brachial plexus nerves. The pectoral
muscle is separated in four distinct regions, and each
brachial plexus nerve is allowed to innervate a separate
area. Surface electrodes placed over the muscle tissue
detect the movement intention.
Kuiken et al, 2007
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well as the transmission of sensory modalities including touch and pain [Kuiken
TA et al, 2007b] to the CNS (Figure 5.3). Although with extremely beneficial
practical applications for patients in the near future, this approach has clear
limits; not only must healthy muscle tissue be compromised in order to provide a
target for regeneration, but also the recovery time and first indications of
reinnervation can be in the order of several months.
While tremendous advancements have been made, there is no approach
to date that directly integrates with the nervous system while leveraging the
processing abilities of the brain and spinal cord. In contrast to all other strategies
for neural interface development, we propose to exploit a novel method of
engineering nervous tissue constructs as a means of interfacing a multi-electrode
array (MEA) with regenerating peripheral nerves. The use of living neural tissue,
which may be coupled to the MEA to form a stable interface prior to
transplantation, provides an enticing target for host axon ingrowth and synaptic
integration (Figure 5.4). By directly accessing the transected nerve, we eliminate
the need for interpreting computationally complex neural signals in the CNS.
Instead, upon integration, simple operant conditioning should allow the implantee
to control the prosthesis with ease [Dhillon GS et al, 2004]. Thus, our approach
builds upon current interface architecture capabilities and holds enormous
promise to provide both motor control and sensory feedback for normal function.
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Figure 5.4: Schematic representation describing the use of stretch‐grown
axonal constructs pre‐attached to an electrode array in a PNS‐based neural
interface system

5.2 Extension and maintenance of host neurites in the absence
of a living distal target, using stretch-grown axons

5.2.1 Relevant Background
When a short segment of a nerve is lesioned, regenerating fibers will
regenerate across the gap and along the distal segment until the end target is
reached. However, if a living distal target is absent, or if the regenerative path is
occluded, the axons will retract and sprout collateral branches, each attempting
to forge a course to the end organ. If this too is not possible, the axons will either
inaccurately innervate surrounding tissue (resulting in the phenomenon of
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phantom pain, which occurs in approximately 10% of patients [Herndon JH et al,
1976]) or will form a painful bulbous enlargement at the site known as a neuroma
[Fried K et al, 1993]. This entire process can occur within weeks, and neuromas
can often persist for months to years.
In general, the fate of a nerve and its end target are considered to be
interlinked – a severed nerve is continuously attempting to reach the target, and
denervated end targets require subsequent reinnervation for their long-term
survival. In order to create a viable neural-electrical interface with a peripheral
nerve, it is crucial that the nerve fascicles be prevented from retracting from the
vicinity of electrode sensors and/or forming a neuroma at the site. In this study,
we evaluate the ability of a stretch-grown neural construct to sustain regenerating
axons for up to 4 weeks in vivo in the absence of a distal target, vis-à-vis static
neural constructs.

5.2.2 Materials and Methods
Dorsal root ganglion neuron isolation
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA)
rats.

The DRG explants were suspended at 5x106 cells/mL in Neurobasal®

medium

supplemented

with

2%

B-27,

0.4

mM

L-glutamine,

1%

penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10
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ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS)
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to
encourage non-neuronal cell elimination.

Static Nervous Tissue Constructs
The explants were plated into a collagen-filled (rat tail type 1, 3.67mg/mL)
agarose (1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA) trough
measuring 2mm x 1cm.

The cell cultures were allowed to form axonal

connections over 12 days in vitro. The neural growth medium described above
was replaced on post-isolation days 1, 3, 5 and 12.

Stretch-grown Nervous Tissue Constructs
The explants were plated into mechanical elongation chambers customfabricated for the stretch-growth procedure. The neurons were plated in two
populations along the interface of a collagen-coated (rat tail type 1, 3.67mg/mL)
aclar “towing” membrane and a base layer of agarose (1.25% in 1X PBS;
Ultrapure, Invitrogen, Carlsbad, CA), resulting in a separation of 50-100µm. Over
5 days in vitro, axonal connections were formed between these two populations.
The populations were then gradually separated over the course of 7 days using a
stepper motor system until the axons spanning them reach a length of 1cm.
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Neural Construct Encapsulation
On post-isolation day 12, the neural cultures (both static and stretchgrown) were removed from the incubation chambers and embedded in a
collagen-based matrix (3.0 mg/mL) in Dulbecco’s modified Eagle’s medium
supplemented with NGF (2.5S, 10 ng/mL). After gelation at 37°C, embedded
cultures were gently removed and placed within a 1cm absorbable collagen
nerve guidance channel (3mm inner diameter, NeuraGenTM, Integra LifeSciences
Corp, Plainsboro, NJ).

Peripheral Nerve Surgery and Tissue Construct Implantation
Stretch-grown (n=6) as well as static (n=6) constructs were implanted into
GFP+ rats (adult male, 400-450mg, strain TgN(act-EGFP)OsbCZ-004).

The

animals were anesthetized with sodium pentobarbital (Nembutal, 50 mg/kg, i.p.)
prior to surgery. A longitudinal skin incision was made in the hind leg from the
sciatic notch proximally to the region of the popliteal fossa distally. The gluteal
muscle was freed up to expose the sciatic nerve and its posterior tibial branch,
and the nerve was transected 1cm proximal to the trifurcation. The proximal
stump was carefully inserted into the NeuraGenTM tube with an overlap of 1mm,
and the epineurium was secured to the tube using 8-0 absorbable sutures. Both
ends of the tube were sealed with salmon fibrin (5mg/ml fibrinogen, 5 NIH
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units/ml thrombin) to provide additional stability. A sterilized strip of polyimide
was then placed over the distal end of the tube and secured to the surrounding
muscle in order to prevent axonal growth out of the tube. Finally, the muscle and
skin layers were sutured over the graft with absorbable chromic gut 4-0 sutures.

Nerve Harvest and Histological Analyses

Figure 5.5: The transplanted neural construct (indicated by the
arrow) being harvested at the 4‐week time point. The construct could
be seen securely connected to the proximal stump. Evidence of
fibrosis and vascularization could be seen along the outside walls of
the collagen tube.
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At 4 weeks post-transplantation, the constructs were harvested by
transecting the nerve 2mm proximal to the graft (Figure 5.5), and were placed in
4% paraformaldehyde. The animals were euthanized by an overdose of sodium
pentobarbital.
Following overnight fixation in paraformaldehyde, the excised tissue was
removed and immersed in 30% sucrose solution.

The tissue was then

cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) myelin basic protein (MBP;
SMI-94R, 1:500, Covance Research Products, Princeton, NJ), (iii) S-100 (1:500;
Dako, Carpinteria, CA), or (iv) calcitonin gene-related peptide (CGRP; C8198,
1:1000 Sigma-Aldrich). The appropriate secondary fluorophore-conjugated
antibodies (TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West
Grove, PA) were used. The sections were examined under an epifluorescent
microscope (Eclipse E600; Nikon, Melville, NY) and the images were digitally
captured (Spot RT Color; Diagnostic Instruments, Sterling Heights, MI).

5.2.3 Results

Host axonal regeneration into stretch-grown constructs
Host axon fibers were seen to extend into the construct tubes and could
be found along their entire length.

These axons were identified as those
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expressing NF-200 co-localized with GFP.

Similar to observations in the

previous study, the axons were observed to preferentially grow between the stilldisintegrating agarose segments and the walls of collagen tube, although in n=4
of 6 cases they did not cross the distal end of the tube. Robust vascularization
could be seen throughout the tubes and alongside the axons. In regions with
axonal sprouting, co-mingling of host and graft (NF200+/GFP-) axonal fibers
could be observed, indicating survival of the graft axons (Figure 5.6). There was
no overt sign of immunologic response as denoted by infiltrating macrophages
and neutrophils despite the lack of immune suppressant usage.

Neuroma formation in static constructs
In the case of static neural constructs (n=6 of 6), the attached nerves
appeared to have undergone excessive collateral sprouting resulting in neuromalike formations by the proximal opening (Figure 5.7). The axons within the nerve
bundles could be clearly identified morphologically, and were also seen to
express GAP-43 co-localized with GFP, a commonly observed marker in
neuromas. Sparse vascularization was seen within the tube. Neither NF-200, nor
GAP-43 nor CGRP were expressed in these vascularized areas or in any other
area of the tube, suggesting that the transplanted cell bodies were no longer
present. Here too, there was no sign of macrophage or neutrophil infiltration at
this time point.
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Figure 5.6: Cross section of the stretch‐grown axonal construct in the
collagen tube (A). The arrow indicates the proximal side. Robust axonal and
vascular infiltration can be seen within the tube, as well as empty pockets
containing un‐disintegrated agarose. No axonal outgrowth was observed
leaving the distal end of the tube. GFP tissue can be seen flanked between the
tube walls and agarose (B). Staining for NF‐200 (red) revealed axons in these
areas (C). Superimposition of these images revealed robust intermingling of
host (yellow) and graft axons (red). Scale bars = 100µm.
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A

B

C

Figure 5.7: Cross section of the static neural construct in the collagen tube (A).
The arrow indicates the proximal side. Large empty regions could be seen
throughout the tube. Note the neuroma formation at the proximal stump, as
characterized by the excessive localized collateral sprouting and positive
identification for GAP-43 (red, B). No axonal ingrowth or graft cell survival
could be seen within the tube, as evidenced by the lack of positive staining for
NF-200. However, vascular infiltration could be clearly observed (C). Scale
bars = 100µm.
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5.3 Regeneration and maintenance of host axons in the vicinity
of a flexible electrode substrate

5.3.1 Relevant Background
Currently, direct stimulating/recording techniques from peripheral nerves
can be broadly grouped into two categories. The first are nerve cuffs, which
have been in clinical usage since the 1960’s and have been implanted in some
patients for as long as 15 years [Glenn WWL et al, 1985; Waters et al, 1985].
These are typically made of inert materials such as platinum-iridium or stainless
steel, encircle the nerve externally and thus do not inflict any direct penetrative
damage to the underlying axonal cytoskeletal structures [Heiduschka and
Thanos, 1998; Naples et al, 1990].

They are also available in a variety of

geometries such as helices [McCreery et al, 1992] and spiral cuffs [Rozman,
1991] that optimize the contact between the nerve and electrode. However, this
design has inherent drawbacks – the electrodes can often impose stretching and
compressive forces on the nerve, the materials can degrade over time, and there
is a reduced likelihood of chronic interface due to nerve degeneration [Krarup et
al, 1989; Larsen et al, 1998].
The second category of nerve-electrodes is intra-fascicular arrays. These
electrodes penetrate at various depths into the nerve depending upon the degree
of sensitivity and control desired [Branner et al, 2004; Lawrence et al, 2003;
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Aoyagi et al 2003]. In the short term, they have been to exhibit enhanced signal
selectivity and high signal-to-noise ratio. However, similar to nerve cuffs, this
approach also has its disadvantages – the materials used are often of poor
biocompatibility, the electrodes themselves can be extremely damaging to the
already traumatized nerves, and nerve degeneration ultimately results in a loss of
the neural-electrical interface.
Building upon the previous study, here we assess axonal growth towards
a thin, flexible polyimide electrode array substrate pre-attached to the axonal
constructs (Figure 5.8), and determine the proximity of regenerating axons to the
substrate surface.

From these observations, we can make a preliminary

assessment of the feasibility of recording electrophysiological activity from the

Figure 5.8: Schematic of proposed neural interface design. The electrode array
is attached to one population of neurons prior to axonal elongation. After
stretch‐growth to 1cm, the construct is embedded in a hydrogel substrate,
placed in a resorbable NeuragenTM tube for structural support, and sutured to
the proximal nerve stump.
Image of FlexMEA array, Multi Channel Systems
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nerve using this approach.
5.3.2 Materials and Methods
Dorsal root ganglion neuron isolation
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA)
rats.

The DRG explants were suspended at 5x106 cells/mL in Neurobasal®

medium

supplemented

with

2%

B-27,

0.4

mM

L-glutamine,

1%

penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10
ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS)
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to
encourage non-neuronal cell elimination.

Stretch-grown Nervous Tissue Constructs
The explants were plated into mechanical elongation chambers customfabricated for the stretch-growth procedure. The neurons were plated in two
populations along the interface of a collagen-coated (rat tail type 1, 3.67mg/mL)
aclar “towing” membrane and a base polyimid strip layered on an agarose bed
(1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA), resulting in a separation
of 50-100µm. Over 5 days in vitro, axonal connections were formed between
these two populations. The populations were then gradually separated over the
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course of 7 days using a stepper motor system until the axons spanning them
reach a length of 1cm.

Neural Interface Encapsulation
On post-isolation day 12, the polyimid/neural cultures (both static and
stretch-grown) were removed from the incubation chambers and embedded in a
collagen-based matrix (3.0 mg/mL) in Dulbecco’s modified Eagle’s medium
supplemented with NGF (2.5S, 10 ng/mL). After gelation at 37°C, embedded
cultures were gently removed and placed within a 1cm absorbable collagen
nerve guidance channel (3mm inner diameter, NeuraGenTM, Integra LifeSciences
Corp, Plainsboro, NJ).

Peripheral Nerve Surgery and Interface Implantation
The stretch-grown constructs (n=4) were implanted into GFP+ rats (adult
male, 400-450mg, strain TgN(act-EGFP)OsbCZ-004).

The animals were

anesthetized with sodium pentobarbital (Nembutal, 50 mg/kg, i.p.) prior to
surgery. A longitudinal skin incision was made in the hind leg from the sciatic
notch proximally to the region of the popliteal fossa distally. The gluteal muscle
was freed up to expose the sciatic nerve and its posterior tibial branch, and the
nerve was transected 1cm proximal to the trifurcation. The proximal stump was
carefully inserted into the NeuraGenTM tube with an overlap of 1mm, and the
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epineurium was secured to the tube using 8-0 absorbable sutures (Figure 5.9A).
Both ends of the tube were sealed with salmon fibrin (5mg/ml fibrinogen, 5 NIH
units/ml thrombin) to provide additional stability. A sterilized strip of polyimide
was then placed over the distal end of the tube and secured to the surrounding
muscle in order to prevent axonal growth out of the tube. Finally, the muscle and
skin layers were sutured over the graft with absorbable chromic gut 4-0 sutures.

Neural Interface Harvest and Histological Analyses
At 4 weeks post-transplantation, the constructs were harvested by
transecting the nerve 2mm proximal to the graft, and were placed in 4%
paraformaldehyde.

The animals were euthanized by an overdose of sodium

pentobarbital.
Following overnight fixation in paraformaldehyde, the excised tissue was
removed and immersed in 30% sucrose solution.

The tissue was then

cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) myelin basic protein (MBP;
SMI-94R, 1:500, Covance Research Products, Princeton, NJ), (iii) S-100 (1:250;
Dako, Carpinteria, CA), or (iv) calcitonin gene-related peptide (CGRP; C8198,
1:1000, Sigma-Aldrich). The appropriate secondary fluorophore-conjugated
antibodies (TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West
Grove, PA) were used. The sections were examined under an epifluorescent
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microscope (Eclipse E600; Nikon, Melville, NY) and the images were captured
digitally (Spot RT Color; Diagnostic Instruments, Sterling Heights, MI).

5.3.3 Results
Gross assessment of neural interface at 4 weeks
At the 4-week time point, the surgical site was re-exposed and the neural
interface was harvested. Fibrosis could be seen surrounding the collagen tube,
but surprisingly the polyimide strip was spared. The polyimide strip/electrode
array was still securely contained within the collagen tube, despite normal
ambulatory movement by the animal during this time (Figure 5.9B). Within the
tube, the proximal stump was seen to have grown into intimate contact with the
electrode array, and both the nerve and electrode array were still secured in
place by the surrounding agarose hydrogel [Figure 5.9C].

Axonal outgrowth in the vicinity of the electrode substrate
A histological evaluation of the constructs revealed host axonal outgrowth in the
immediate vicinity of the polyimide strip. NF-200+ (Figure 5.10D) and tau-positive
(Figure 5.10B,C) staining was observed at distances ranging from 100-200um
from the substrate.

Vascular ingrowth was also observed in the region,

portending well for continued survival of these axons.
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Figure 5.9: (A) The neural interface, consisting of the stretch‐
grown axons attached to the polyimide substrate (indicated by
the arrows) within a NeuraGenTM tube being sutured to the
proximal stump of the rat sciatic nerve. (B) The neural
interface being harvested at the 4‐week time point. Note the
fibrosis surrounding the tube, but minimal response by the
polyimide strip. (C) Visual assessment within the tube
revealed the proximal stump in close physical proximity to the
end of the polyimide strip.
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D

Figure 5.10: (A) Cross section of the harvested neural interface at
4 weeks. The polyimide strip (black arrow) and the proximal
stump (red arrow) can be clearly seen. (B‐C) Axon fibers,
identified by tau‐positive staining (red) can be clearly seen in close
proximity to the polyimide electrode array (white arrow). (D)
Regenerating axons, identified by NF‐200 staining (yellow) can be
seen within host tissue (GFP, green) running closely alongside the
polyimide strip (white arrow). Scale bar = 100µm.
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5.4 Discussion
This project demonstrates a means of extending and maintaining a transected
nerve segment in the absence of a distal pathway, with the goal of ultimately
recording electrophysiological signals from the host axons using an implanted
electrode array.

While the results are admittedly preliminary, they provide

support for further study and development of this novel PNS-based neural
interface platform.

Extension and maintenance of regenerating neurites
A confounding factor in the development of peripheral nerve-based neural
interface systems has been the inability to preserve electrical contact with the
remaining nerve segment over the long-term. The primary reason for this is the
unfavorable, and often physically damaging, environment created around the
nerve fascicles when rigid metal electrodes are placed in their immediate vicinity
[Navarro X et al, 2005]. The presence of the electrodes invariably triggers a
robust immunologic response and connective tissue buildup, rendering the
neural-electrical coupling ineffectual over the long-term [Stieglitz T, 2004; Larsen
et al, 1998].

In addition, the electrodes themselves can cause compressive

and/or penetrative stress on the neurites, further harming already impaired
nerves [Rodriguez FJ et al, 2000; Grill WR and Mortimer JT, 1998].
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A successful PN interface design must therefore incorporate components
that actively encourage neurite outgrowth towards them, in addition to being
compliant enough to prevent damage during the course of normal activity. Since
Schwann cells play a pivotal role in regeneration, they have been extensively
used in so-called hybrid interface designs. The most sophisticated of these are
regenerative sieve electrodes – in this design, axons are induced to grow across
a finely perforated barrier into a chamber containing a short segment of distal
nerve and Schwann cell cultures [Lago N et al, 2009]. Axons have been shown
to grow into the chamber and survive for several months. However, there are a
number of disadvantages with this approach including the limited regeneration
across the barrier, frequent axotomy that occurs during normal ambulatory
movement, neuroma formation over the short-term, competition between neurites
and proliferating Schwann cells for volume, and the eventual atrophy and
retraction of the axons [Navarro X et al, 2005].
Building upon these studies and our previous results where it was shown
that living stretch-grown axonal constructs provide regenerative support for
transected fascicles, their ability to maintain axons in the absence of a distal
target was initially evaluated in this study.

Neural constructs (stretch-grown,

static and control) were transplanted against a transected proximal nerve
segment, and the extent of axonal ingrowth was measured.

At 4 weeks,

extensive axonal sprouting and neuroma formation was seen in the static groups
at the site of suture of the stump. This is comparable to the response seen after
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post-transectional nerve capping [Galeano M et al, 2009]. The animals had
suffered extensive automutilation, presumably as a result of the neuroma
formation [Zeltser R et al, 2000].

Neurofilament staining did not reveal the

presence of axons nor graft cell bodies within the tubes, indicating that the static
cultures may not have survived at this time point.

It is unclear whether the

axonal regeneration occurred at all, or after nerve ingrowth and subsequent
retraction. Since the distal end of the tube was sealed, all vascularization seen
must have originated at the proximal end of the tube.

This form of

vascularization typically accompanies nerve regeneration [Best TJ et al, 1999],
however, suggesting that abortive reinnervation may indeed have occurred. The
stretch-grown construct group showed evidence of neurite ingrowth, albeit
sparse, and graft axon survival in those areas. No neuromas were evident in this
group, and automutilation was much less pronounced.

Evaluation of the neural interface in vivo
Following from these results, a commercially available flexible electrode
array made of polyimide PI12611 was incorporated into the pre-stretch design,
enabling the creation of a fully-formed neural-electrical interface in vitro.
Polyimide was selected as the base material as it has been shown to be durable,
flexible, capable of being implanted over several years, and inciting only minimal
fibrotic response [Lago N et al, 2007; Klinge et al, 2001; Navarro et al, 1998].
This interface was transplanted against the transected sciatic nerve, and left in
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vivo for 4 weeks.

A gross evaluation of the neural interface upon removal

showed that interface design is capable of withstanding normal ambulatory
movement of the animal, at least in the acute phase. Fibrous tissue was seen
surrounding the collagen conduit, which paradoxically may have provided
additional stability.

The polyimide strip, however, was surprisingly devoid of

fibrous tissue even in this acute time frame, suggesting that it may be capable of
withstanding host rejection within this design over a longer period.
Careful exposure of the tube revealed a proximal stump that was now in
the close contact with the polyimide strip. Unlike in the previous study where
only sparse host ingrowth was seen, here the nerve appeared to be of a much
more robust girth.

This may be a result of the pre-coated polyimide strip

presenting a favorable 2-dimensional regenerative surface for the nerve to grow
along [Bellamkonda RV, 2006]. It should be noted that although the agarose gel
kept the nerve and polyimide in close contact, manipulation of the nerveelectrode interface revealed a weak adhesion. This may be a result of minimal
fibrotic infiltration due to the use of the salmon fibrin sealant – chronically
implanted polyimide nerve cuffs maintain their neural connection only upon
encapsulation by fibrous tissue [Rodriguez FJ et al, 2000]. It remains to be seen
if a beneficial fibrotic response occurs after enzymatic degradation of the agarose
and fibrin.
Histological evaluation of the nerve-electrode contact revealed axonal
growth in close proximity to the polyimide surface. The separation ranged from
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100-200µm, as demonstrated by NF200 and Tau staining.

In comparison,

polyimide nerve cuff electrodes can consistently stimulate and record axonal
activity at distances of up to 400µm [Naples GG et al, 1990], suggesting that the
axon-electrode separation observed here is electrophysiologically viable.
Finally, while the stretch-grown axons have been shown to be
electrophysiologically functional [Pfister BJ et al, 2006], there was no evidence of
host synaptic integration with either of the graft cell body populations. Although
the design goal of this project was simply to coax axonal growth into the vicinity
of the electrode substrate, such synaptic integration could also provide a
mechanism for stable neuro-electrical interfacing over the long-term, and thus
warrants further investigation.

5.5 SUMMARY OF FINDINGS:

Conclusions
In the absence of the appropriate distal target with which to integrate,
regenerating axons will retract and sprout numerous collateral branches that then
either inaccurately innervate surrounding tissue or coalesce into a neuroma at
the site. Here, we demonstrate a method of extending and maintaining these
axons for at least 4 weeks with retraction, despite the absence of an end target,
using living stretch-grown axonal tracts. We then harnessed this phenomenon to
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entice host neurite growth into close contact with an implanted electrode
substrate, potentially enabling recording and/or stimulation from these fascicles.
host axonal growth into close contact with an implanted electrode substrate.
While our findings are preliminary, they represent an important initial step in
evaluating the feasibility of this novel bio-electrical hybrid platform for long-term
interfacing with the peripheral nervous system.

Limitations and Future Studies
The principal limitations of this study are two-fold. First, while the findings
are suggestive of the advantages offered by stretch-grown axons, a clearer
understanding can only be reached by using a larger sample size per group. In
particular, a quantification of the number of axon fibers in the vicinity of the
electrode will enable us to determine critical design characteristics and sensitivity
of the electrodes themselves.
The second important limitation is the acute time point – while the 4-week
time point was selected in order to understand and solve the short-term design
challenges, a thorough understanding of the benefits of this approach can only
be reached after several months of implantation. It is vital to determine whether
the axons can be maintained in proximity to the array for months to years, as well
as if they demonstrate signs of continued development, such as fasciculation and
myelination, which are essential for robust electrophysiological function. Based
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on our results, we believe that a comprehensive histological assessment of the
neural interface at 6 months and 1 year in vivo is merited.
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Chapter 6

Synthesis and Future Work
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Chapter 6: Synthesis and Future Work

6.1 Introduction
Peripheral nerve damage following trauma can often be a debilitating
condition resulting in pain and disability for prolonged periods. In its most severe
form, the entire nerve trunk is transected resulting in complete discontinuity and a
total loss of function without surgical intervention.

If the distal stump is still

present, bridging techniques using nerve guidance channels can be employed;
however, if the injury is too extensive or too proximally located, the prognosis is
invariably poor. If a distal pathway is absent, as in the case of a limb amputation,
the nerve will either aberrantly innervate surrounding tissue or form a neuroma at
the site. Without a suitable means to chronically record intent-related activity
from the nerve, it essentially becomes extraneous.
The purpose of this study was to evaluate the ability of transplantable
nervous tissue constructs to augment natural regeneration of transected
peripheral nerves in order to (1) enable repair of a short lesion at both the
proximal and distal ends, and (2) facilitate extensive and maintenance of the
axons in the absence of a distal target, with the ultimate goal of creating a bidirectional neural interface with the PNS.
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6.2 Summary and Synthesis of Major Findings

The first major goal in this project was to create a stable and reproducible
encapsulation methodology for the axonal constructs. Previous collagen gelbased encapsulation schemes provided minimal physical support for the axonal
constructs, resulting in frequent disruption of the tracts during removal from the
culture environment. The stretch-growth protocol was modified to incorporate
agarose hydrogel as the base layer upon which cell bodies were plated, and the
optimal parameters for neurite outgrowth and tissue encapsulation were
determined. Finally, salmon fibrin was incorporated as an end sealant at the time
of implantation, in order to attenuate macrophage and glial infiltration as well as
provide additional stability at the site of the suture. The salmon fibrin appeared
to have contributed to the slow disintegration of the agarose over the initial 4
weeks, although this disintegration was complete within 8 weeks. Since allograft
tissue is employed in these studies, the benefit provided by the fibrin in
preventing macrophage infiltration outweighs the short-term drawbacks, and as
such it will continue to be incorporated into the transplantation design.
Stretch-grown axonal constructs appeared to offer a clear benefit over
static neural populations in repairing short PNS lesions. This benefit was most
apparent during electrophysiological evaluation, where a statistically significant
difference in the conduction velocity ratios was observed.

This appeared to

correlate with the extent of regeneration seen within the graft tubes; the axonal
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construct group appeared to demonstrate robust neural and vascular growth
through the tube, whereas growth was limited to along the walls in the static
group.

This suggests that regenerating neurites, and their accompanying

vasculature, preferentially proceed along aligned axonal pathways, in a process
approximating naturally occurring axon-mediated axon growth. The neural cell
bodies themselves, which are entirely absent in the periphery, may simply be
indiscernible to the host axons and thus provide no therapeutic benefit.
On the other hand, these cell bodies – and, more specifically, the neurites
emanating from them – seem to play a significant role in maintaining the distal
pathway far longer than naturally possible. The morphology of the distal stump
at 4 months resembled that of control nerves at 2 weeks, thus potentially
increasing the time window within which successful reinnervation may occur.
The absence of any surviving neurites and cell bodies suggests, however, that
this protective effect is transient. In the vast majority of cases, reinnervation of
the distal pathway will have occurred within this timeframe. However, for very
extensive lesions this delay may itself not be sufficient. The use of immune
suppressants may be able to prolong the eventual atrophy of the grafted cells,
and would be an important future area of study.
Stretch-grown axons were also shown to enable host axons regeneration
and maintenance for 4 weeks without the presentation of any distal target. This
runs contrary to conventional dogma, wherein regenerating neurites will retract
and attempt collateral branching in the continued pursuit of a target. Excessive
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collateral branching often leads to neuroma formation – indeed, this was
uniformly observed in static culture group. The mechanisms by which the axonal
constructs enable this axonal maintenance is unclear, as is the temporal limits if
any. However, we did observe that incorporating an electrode substrate into the
design enabled host axonal growth into its vicinity. The extent of host infiltration
as well as the long-term behavior of these axons will need to be quantified in
order for this neural-interface platform to be feasible. However, the short-term
results obtained thus far merit a more comprehensive investigation of this
architecture.

6.3 Future Work
The preceding studies described a novel method of repairing nerve lesion,
and potentially interfacing with the peripheral nervous system, using engineered
living nervous tissue. However, several areas warrant further study which should
be considered for future investigations.

Developing transplantable axon tracts
Currently the axonal tracts generated are planar in nature – this is
particularly disadvantageous during removal from culture environment for nerve
repair applications, where the tracts need to be compressed into a narrow tube in
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order to achieve a reasonable axon density. An important solution to this would
be to create 3-dimensional axonal tracts that conform to the dimensions of the
nerve guidance channels. We are evaluating the use of various hydrogels as the
embedding matrix, and will modify the stretch-growth chambers to incorporate
these structures.

Repair of PNS lesions
A more thorough understanding of the precise benefit offered by the
stretch-grown axons is needed. While methods such as electrophysiology are
immensely informative, it would be useful to correlate this information with a
more quantitative assessment of the regeneration, including axonal density,
myelination, etc. In addition, earlier (less than 2 weeks) and later (greater than 4
months) time points would be useful in determining the rate of regeneration and
then extent and nature of reinnervation (motor versus sensory). A clearer
understanding is also needed of the mechanisms by which axonal constructs
augment host axonal regeneration.
components

(chemotaxic

regeneration.

and/or

It would be important to isolate those
haptotaxic)

that

especially

influence

By doing so, we may be able to create artificial conduits

incorporating these elements, thus eliminating the need for living tissue
transplantation.
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For distal degeneration, it is important to determine the mechanism by
which the constructs provided pathway maintenance, as well as the reasons for
their eventual degradation. Evaluation at an earlier time point would be useful in
determining the lifespan of the constructs.

Finally, the use of immune

suppressants or other agents as a means of prolonging their survival would be
important to determine.

Development of a neural interface
A clearer quantitative understanding of the extent and nature of the
regenerating axons is critical in determining the viability of this neural interface
platform. While axon retraction and neuroma formation were not observed in the
acute phase, this must be verified over the long-term. An evaluation of the host
axon density and myelination must also be performed in order to determine the
appropriate electrical characteristics of the electrodes.

Finally, an improved

integrated electrode design needs to be developed. Although we are merely
evaluating the feasibility of this approach using a variety of commercially
available components, none of them have been developed for this application. A
more appropriate neural-interface design would incorporate a multi-channel
electrode substrate encapsulating a 3-dimensional nervous tissue construct.
Such a design would allow for more robust host innervation, and potentially
enable selective stimulation and recording from individual fascicles.
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6.4 Conclusion
In summary, this thesis demonstrates the feasibility of using engineered
nervous tissue constructs in the repair of peripheral nerve lesions and
amputations. While this is only a preliminary analysis, further development of
these techniques may result in clinically applicable therapeutic strategies for
extensive nervous system repair.

‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
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